Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.Tracy A. Brooks, Iwao Ojima, Paula Pera et al.|PubMed|2003Cited by 118
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023Hans Minderman, Maria R. Baer, Tracy A. Brooks et al.|Cancer Chemotherapy and Pharmacology|2004Cited by 51
Design, Synthesis and Structure−Activity Relationships of Novel Taxane-Based Multidrug Resistance Reversal AgentsIwao Ojima, Ralph J. Bernacki, Christopher P. Borella et al.|Journal of Medicinal Chemistry|2005Cited by 35
Structure-activity analysis of taxane-based broad-spectrum multidrug resistance modulators.Tracy A. Brooks, Ralph J. Bernacki, Maria R. Baer et al.|PubMed|2004Cited by 25